Home
Point of Care
Cardiac
Cardiale Merkers
Atellica® VTLi Patient-side Immunoassay Analyzer

Atellica® VTLi Patient-side Immunoassay Analyzer
A vital leap forward in cardiac testing

When a patient enters the emergency department presenting with the symptoms of a myocardial infarction (MI), every moment is critical. Achieving favorable clinical and operational outcomes requires fast and accurate chest pain assessment at the point of care, as well as coordination with the laboratory for quality assurance. Having high-sensitivity troponin testing at the point of care—producing accurate results in just 8 minutes—could transform care delivery for millions of people each year, improving ED throughput, reducing stress and strain on acute care clinicians, and aiding in optimizing the use of time and resources of busy laboratories.

SCA Scientists' Choice Awards Winner 2022

Scientists' Choice Awards 2022 Winner!

The winner of the Clinical Video Interview of the Year was our very own ‘High-sensitivity cardiac troponin assays and the power of point of care in the emergency department’ which is an interview with Dr. Frank Peacock, professor of emergency medicine and vice chair of research, department of emergency medicine at Baylor College of Medicine.

In the winning video, Peacock discusses the importance of cardiac troponin as a biomarker for myocardial infarction, highlights the benefits of high-sensitivity versus contemporary troponin assays, and shares why point-of-care testing is a powerful tool in the emergency department.

Watch the video

Features & Benefits

Simple to use and easily integrated into existing systems, the Atellica® VTLi Patient-side Immunoassay Analyzer, powered by Magnotech® Technology, delivers accurate, clinically actionable high-sensitivity troponin I results directly in the hands of those who need it most.

View from the patient’s perspective of EMTs and hospital staff wearing masks and gloves assisting after a myocardial infarction

Improved ED throughput

The Atellica VTLi system streamlines chest pain assessment, aiding in earlier disposition decisions for patients not having an MI and fast interventions for those who are.

Evidence-based, accurate performance

The Atellica VTLi system offers hs-cTnI testing right at the point of care. Results are available in just minutes for clinicians and laboratory partners.

A nurse holding the Atellica VTLi Analyzer reviews cardiac test results with a doctor while attending to a patient in a hospital bed

Easily integrated into assessment processes

The Atellica VTLi system will aid in transforming your chest pain assessment process to benefit patients, clinicians, and operational workflow.

Assays

Parameter	Unit of Measure	Measurement Range
High-Sensitivity Cardiac Troponin I (hs-cTnI)	ng/L*	LoD - 1,250 LoD plasma 1.2 LoD Whole blood 1.6
BNP^†

* for hs-cTnI

† This product is under development and not commercially available. Its future availability cannot be ensured.

Technical Details

Sample Type	Whole blood (lithium heparin) Venous (lithium heparin) Capillary

Sample Size	30–100 μL

Analysis
Time to Results	~8 minutes

Quality Control	Sero PATHONORM Cardiac Acute Liq

Reagent Cartridge
Storage	2–8°C
Size of box (W x D x H)	152 x 95 x 167 mm
Cartridges per box	24

System Dimensions
Length	25 cm
Height	5.2 cm
Width	8.5 cm
Weight	780 g
Color LCD display	7.3 inches

Integrated Barcode Scanner	Patient ID, Operator ID, and bottled QC; 1D (linear) and 2D barcode symbologies

Operating System	Microsoft WEC2013

Data Security	Patient data anonymization TLS 1.2 encrypted end-to-end communication, using client and server certificates Configurable level of user authentication No storage of passwords, no hard-coded passwords No user access to operating system

Access Educational Resources

Services & Support

Vond u deze informatie nuttig?